Article challenges Terence Tao's take on AI cancer therapy acceptance
What happened
An article on the Hacker News front page on October 11 pushed back on Terence Tao's claim that patients will accept AI cancer therapies only once human experts understand them. It argues that therapies passing phase 3 randomized controlled trials get accepted even when their mechanism is unclear, citing Adriamycin, docetaxel, ibrutinib and venetoclax, and noting that existing cancer drugs are not fully understood either. Cancer patients also accept treatments with thinner evidence in some situations, the article says, while warning that unproven therapies can cause harm.
Written by AI from the coverage · updated 1 hour ago
Coverage
Follow the reports to see the story from different sides.
- Hacker News front pageTerrence Tao does not understand cancer medicine
文章反驳 Terrence Tao 关于患者需要人类专家理解 AI 癌症疗法才愿接受治疗的判断，主张通过 phase 3 随机对照试验的疗法即使机制不明也会被接受。文章列举 Adriamycin、docetaxel、ibrutinib 和 venetoclax，强调现有抗癌药的作用机制也未被完全理解。文中进一步指出，癌症患者在特定情况下会接受证据更有限的治疗，同时警告未经证实的疗法可能造成伤害。
Heat over time
Not enough continuous observations to draw a trend yet.